Timothy M Hughes1, Lewis H Kuller2, Emma J M Barinas-Mitchell2, Eric M McDade3, William E Klunk4, Ann D Cohen4, Chester A Mathis5, Steven T Dekosky6, Julie C Price5, Oscar L Lopez3. 1. Department of Internal Medicine, Wake Forest School of Medicine, Wake Forest University, Winston-Salem, North Carolina. 2. Department of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania. 3. Department of Neurology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 4. Department of Psychiatry, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 5. Department of Radiology, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania. 6. Department of Neurology, School of Medicine, University of Virginia, Charlottesville.
Abstract
IMPORTANCE: Recent studies show that cerebral β-amyloid (Aβ) deposition is associated with blood pressure and measures of arterial stiffness in nondemented individuals. OBJECTIVE: To examine the association between measures of arterial stiffness and change in Aβ deposition over time. DESIGN, SETTING, AND PARTICIPANTS: Deposition of Aβ was determined in a longitudinal observational study of aging by positron emission tomography using the Pittsburgh compound B twice 2 years apart in 81 nondemented individuals 83 years and older. Arterial stiffness was measured with a noninvasive and automated waveform analyzer at the time closest to the second positron emission tomography scan. All measures were performed under standardized conditions. Pulse wave velocity (PWV) was measured in the central (carotid-femoral and heart-femoral PWV), peripheral (femoral-ankle PWV), and mixed (brachial-ankle PWV) vascular beds. MAIN OUTCOMES AND MEASURES: The change in Aβ deposition over 2 years was calculated from the 81 individuals with repeat Aβ-positron emission tomography. RESULTS: The proportion of Aβ-positive individuals increased from 48% at baseline to 75% at follow-up. Brachial-ankle PWV was significantly higher among Aβ-positive participants at baseline and follow-up. Femoral-ankle PWV was only higher among Aβ-positive participants at follow-up. Measures of central stiffness and blood pressure were not associated with Aβ status at baseline or follow-up, but central stiffness was associated with a change in Aβ deposition over time. Each standard deviation increase in central stiffness (carotid-femoral PWV, P = .001; heart-femoral PWV, P = .004) was linked with increases in Aβ deposition over 2 years. CONCLUSIONS AND RELEVANCE: This study showed that Aβ deposition increases with age in nondemented individuals and that arterial stiffness is strongly associated with the progressive deposition of Aβ in the brain, especially in this age group. The association between Aβ deposition changes over time and generalized arterial stiffness indicated a relationship between the severity of subclinical vascular disease and progressive cerebral Aβ deposition.
RCT Entities:
IMPORTANCE: Recent studies show that cerebral β-amyloid (Aβ) deposition is associated with blood pressure and measures of arterial stiffness in nondemented individuals. OBJECTIVE: To examine the association between measures of arterial stiffness and change in Aβ deposition over time. DESIGN, SETTING, AND PARTICIPANTS: Deposition of Aβ was determined in a longitudinal observational study of aging by positron emission tomography using the Pittsburgh compound B twice 2 years apart in 81 nondemented individuals 83 years and older. Arterial stiffness was measured with a noninvasive and automated waveform analyzer at the time closest to the second positron emission tomography scan. All measures were performed under standardized conditions. Pulse wave velocity (PWV) was measured in the central (carotid-femoral and heart-femoral PWV), peripheral (femoral-ankle PWV), and mixed (brachial-ankle PWV) vascular beds. MAIN OUTCOMES AND MEASURES: The change in Aβ deposition over 2 years was calculated from the 81 individuals with repeat Aβ-positron emission tomography. RESULTS: The proportion of Aβ-positive individuals increased from 48% at baseline to 75% at follow-up. Brachial-ankle PWV was significantly higher among Aβ-positive participants at baseline and follow-up. Femoral-ankle PWV was only higher among Aβ-positive participants at follow-up. Measures of central stiffness and blood pressure were not associated with Aβ status at baseline or follow-up, but central stiffness was associated with a change in Aβ deposition over time. Each standard deviation increase in central stiffness (carotid-femoral PWV, P = .001; heart-femoral PWV, P = .004) was linked with increases in Aβ deposition over 2 years. CONCLUSIONS AND RELEVANCE: This study showed that Aβ deposition increases with age in nondemented individuals and that arterial stiffness is strongly associated with the progressive deposition of Aβ in the brain, especially in this age group. The association between Aβ deposition changes over time and generalized arterial stiffness indicated a relationship between the severity of subclinical vascular disease and progressive cerebral Aβ deposition.
Authors: Howard J Aizenstein; Meryl A Butters; Kristi A Clark; Jennifer L Figurski; V Andrew Stenger; Robert D Nebes; Charles F Reynolds; Cameron S Carter Journal: Neurobiol Aging Date: 2005-06-01 Impact factor: 4.673
Authors: Victor L Villemagne; Samantha Burnham; Pierrick Bourgeat; Belinda Brown; Kathryn A Ellis; Olivier Salvado; Cassandra Szoeke; S Lance Macaulay; Ralph Martins; Paul Maruff; David Ames; Christopher C Rowe; Colin L Masters Journal: Lancet Neurol Date: 2013-03-08 Impact factor: 44.182
Authors: Chester A Mathis; Lewis H Kuller; William E Klunk; Beth E Snitz; Julie C Price; Lisa A Weissfeld; Bedda L Rosario; Brian J Lopresti; Judith A Saxton; Howard J Aizenstein; Eric M McDade; M Ilyas Kamboh; Steven T DeKosky; Oscar L Lopez Journal: Ann Neurol Date: 2013-04-17 Impact factor: 10.422
Authors: Thaddeus J Haight; Susan M Landau; Owen Carmichael; Christopher Schwarz; Charles DeCarli; William J Jagust Journal: JAMA Neurol Date: 2013-08 Impact factor: 18.302
Authors: Connie W Tsao; Sudha Seshadri; Alexa S Beiser; Andrew J Westwood; Charles Decarli; Rhoda Au; Jayandra J Himali; Naomi M Hamburg; Joseph A Vita; Daniel Levy; Martin G Larson; Emelia J Benjamin; Philip A Wolf; Ramachandran S Vasan; Gary F Mitchell Journal: Neurology Date: 2013-08-09 Impact factor: 9.910
Authors: Timothy M Hughes; Lewis H Kuller; Emma J M Barinas-Mitchell; Rachel H Mackey; Eric M McDade; William E Klunk; Howard J Aizenstein; Ann D Cohen; Beth E Snitz; Chester A Mathis; Steven T Dekosky; Oscar L Lopez Journal: Neurology Date: 2013-10-16 Impact factor: 9.910
Authors: Timothy M Hughes; Andrew D Althouse; Nancy A Niemczyk; Marquis S Hawkins; Allison L Kuipers; Kim Sutton-Tyrrell Journal: Cardiovasc Diabetol Date: 2012-09-22 Impact factor: 9.951
Authors: Julia A Scott; Meredith N Braskie; Duygu Tosun; Pauline Maillard; Paul M Thompson; Michael Weiner; Charles DeCarli; Owen T Carmichael Journal: Neurobiol Aging Date: 2016-08-24 Impact factor: 4.673
Authors: Kevin S Heffernan; Nicole L Spartano; Jacqueline A Augustine; Wesley K Lefferts; William E Hughes; Gary F Mitchell; Randall S Jorgensen; Brooks B Gump Journal: Am J Hypertens Date: 2014-11-10 Impact factor: 2.689
Authors: Matthew P Pase; Alexa Beiser; Jayandra J Himali; Connie Tsao; Claudia L Satizabal; Ramachandran S Vasan; Sudha Seshadri; Gary F Mitchell Journal: Stroke Date: 2016-08-04 Impact factor: 7.914
Authors: Chendi Cui; Akira Sekikawa; Lewis H Kuller; Oscar L Lopez; Anne B Newman; Allison L Kuipers; Rachel H Mackey Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472